165 related articles for article (PubMed ID: 23785232)
1. Inhaled anticholinergic use and all-cause mortality among elderly Medicare beneficiaries with chronic obstructive pulmonary disease.
Ajmera M; Shen C; Pan X; Findley PA; Rust G; Sambamoorthi U
Int J Chron Obstruct Pulmon Dis; 2013; 8():287-94. PubMed ID: 23785232
[TBL] [Abstract][Full Text] [Related]
2. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
[TBL] [Abstract][Full Text] [Related]
3. Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis.
Ajmera M; Raval AD; Shen C; Sambamoorthi U
Int J Chron Obstruct Pulmon Dis; 2014; 9():339-48. PubMed ID: 24748785
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular safety of inhaled long-acting bronchodilators in individuals with chronic obstructive pulmonary disease.
Gershon A; Croxford R; Calzavara A; To T; Stanbrook MB; Upshur R; Stukel TA
JAMA Intern Med; 2013 Jul; 173(13):1175-85. PubMed ID: 23689820
[TBL] [Abstract][Full Text] [Related]
5. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Singh S; Loke YK; Furberg CD
JAMA; 2008 Sep; 300(12):1439-50. PubMed ID: 18812535
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for reflux esophagitis in patients with chronic obstructive pulmonary disease.
Kim SW; Lee JH; Sim YS; Ryu YJ; Chang JH
Korean J Intern Med; 2014 Jul; 29(4):466-73. PubMed ID: 25045294
[TBL] [Abstract][Full Text] [Related]
7. Association between smoking behavior patterns and chronic obstructive pulmonary disease: a long-term follow-up study among Finnish adults.
Hukkinen M; Korhonen T; Heikkilä K; Kaprio J
Ann Med; 2012 Sep; 44(6):598-606. PubMed ID: 21612334
[TBL] [Abstract][Full Text] [Related]
8. Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.
Salpeter SR
Drugs; 2009 Oct; 69(15):2025-33. PubMed ID: 19791824
[TBL] [Abstract][Full Text] [Related]
9. Inhaled anticholinergics for chronic obstructive pulmonary disease: comment on "Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease".
Singh S; Furberg CD
Arch Intern Med; 2011 May; 171(10):920-2. PubMed ID: 21606097
[No Abstract] [Full Text] [Related]
10. Inhaled anticholinergic drugs and risk of acute urinary retention.
Afonso AS; Verhamme KM; Stricker BH; Sturkenboom MC; Brusselle GG
BJU Int; 2011 Apr; 107(8):1265-72. PubMed ID: 20880196
[TBL] [Abstract][Full Text] [Related]
11. Anticholinergics aggravate the imbalance of the autonomic nervous system in stable chronic obstructive pulmonary disease.
Yuan W; Nie S; Wang H; Xu Q; Jia N
BMC Pulm Med; 2019 May; 19(1):88. PubMed ID: 31072407
[TBL] [Abstract][Full Text] [Related]
12. Use of inhaled anticholinergic agents in obstructive airway disease.
Restrepo RD
Respir Care; 2007 Jul; 52(7):833-51. PubMed ID: 17594728
[TBL] [Abstract][Full Text] [Related]
13. Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study.
Stephenson A; Seitz D; Bell CM; Gruneir A; Gershon AS; Austin PC; Fu L; Anderson GM; Rochon PA; Gill SS
Arch Intern Med; 2011 May; 171(10):914-20. PubMed ID: 21606096
[TBL] [Abstract][Full Text] [Related]
14. Dual Medicare and Veteran Health Administration use and ambulatory care sensitive hospitalizations.
Ajmera M; Wilkins TL; Sambamoorthi U
J Gen Intern Med; 2011 Nov; 26 Suppl 2(Suppl 2):669-75. PubMed ID: 21989620
[TBL] [Abstract][Full Text] [Related]
15. Understanding gender differences in statin use among elderly Medicare beneficiaries: an application of decomposition technique.
Bhattacharjee S; Findley PA; Sambamoorthi U
Drugs Aging; 2012 Dec; 29(12):971-80. PubMed ID: 23160960
[TBL] [Abstract][Full Text] [Related]
16. Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators.
Keshishian A; Xie L; Dembek C; Yuce H
Clin Ther; 2019 Nov; 41(11):2283-2296. PubMed ID: 31630815
[TBL] [Abstract][Full Text] [Related]
17. Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids.
Salpeter SR; Buckley NS
Clin Rev Allergy Immunol; 2006; 31(2-3):219-30. PubMed ID: 17085795
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic Prescribing in Medicare Part D Beneficiaries Residing in Nursing Homes: Results from a Retrospective Cross-Sectional Analysis of Medicare Data.
Niznik J; Zhao X; Jiang T; Hanlon JT; Aspinall SL; Thorpe J; Thorpe C
Drugs Aging; 2017 Dec; 34(12):925-939. PubMed ID: 29214512
[TBL] [Abstract][Full Text] [Related]
19. Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease.
Qian J; Simoni-Wastila L; Langenberg P; Rattinger GB; Zuckerman IH; Lehmann S; Terrin M
J Am Geriatr Soc; 2013 May; 61(5):754-61. PubMed ID: 23617752
[TBL] [Abstract][Full Text] [Related]
20. Two-year changes in health and functional status among elderly Medicare beneficiaries in HMOs and fee-for-service.
Riley G
Health Serv Res; 2000 Dec; 35(5 Pt 3):44-59. PubMed ID: 16148951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
